ArticleEuropean journal of drug metabolism and pharmacokinetics2026
Selective and Time-Dependent Alterations in Cytochrome P450 (CYP) Enzyme Activity and Expression by Major Phytocannabinoids.
Article in European journal of drug metabolism and pharmacokinetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND AND
objectiveThe legalization of cannabis in many parts of the USA and worldwide emphasizes the need to study their potential for interaction with drugs. The Cannabis sativa plant contains over 120 phytocannabinoids, with delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN) being the most abundant cannabinoids. The aim of this study was to investigate the effect of treatment with individual cannabinoids or mixture of cannabinoids (mix) on the activity and expression of several cytochrome P450 (CYP) enzymes.
methodsPrimary cultures of human hepatocytes were pretreated with either vehicle or cannabinoids, followed by incubation with a cocktail of CYP substrates. The activity of various CYP enzymes was determined by quantifying the formation of the metabolites of specific CYP substrates using liquid chromatography-tandem mass spectrometry. The messenger RNA (mRNA) expression of various CYP enzymes was determined by quantitative real-time polymerase chain reaction (qrt-PCR).
resultsA significant (> 2-fold) increase in CYP1A2 activity was observed after chronic exposure to CBN and mix at 3 µM. Similarly, THC and mix treatments at 3 µM led to a significant (> 2-fold) increase in CYP3A4 activity and expression. No major inducive effects were observed on CYP2D6 and CYP2C9. Acute exposure to CBD, CBN, or mix inhibited CYP1A2 activity in a concentration-dependent manner; mix showed mild CYP3A4 inhibition at 3 µM with no major effects on CYP2D6 and CYP2C9 activity.
conclusionsThese data suggest that cannabinoids selectively alter the activity and expression of CYP enzymes, which may lead to change in exposure of coadministered substrates owing to possible metabolic drug-drug interactions (DDI).
Identifiers
42663925What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.